Skip to content

BrightSpring Health Services

US · BTSG #1332 by market cap Listed 2024
62.84 -1.18 -1.84%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Valuation each multiple against its own 5-year range

P/B ratio 6.51 Expensive vs history 95th percentile
5-year average 3.17 · #30 of 37 in Health Information Services
P/E ratio 38.28 In line with history 56th percentile
5-year average 8.46 · forward 32.45 · #6 of 16 in Health Information Services
P/S ratio 0.93 Expensive vs history 95th percentile
5-year average 0.44 · forward 0.80 · #15 of 41 in Health Information Services

Vs. peers Health Information Services

Company Market cap P/E (TTM) P/B Div yield
BrightSpring Health Services (BTSG) 12.50B 33.78 5.75 0.00%
Veeva Systems (VEEV) 43.10B 43.64 5.80 0.00%
Tempus AI (TEM) 9.86B -50.98 19.70 0.00%
Hinge Health (HNGE) 8.60B 51.68 28.71 0.00%
HealthEquity (HQY) 7.84B 34.21 3.94 0.00%
Doximity (DOCS) 5.13B 39.90 5.52 0.00%

Other StockVane-tracked companies in the same industry.

Morningstar

★☆☆☆☆ Fair value53.72 Economic moatNarrow UncertaintyHigh

Trading 14.5% above Morningstar's fair value estimate.

Fair value

BrightSpring Health Services Inc earns a 1-star quantitative star rating, indicating our belief that this share class poses considerable downside risk. Those looking for diamonds in the rough should steer clear. The stock currently trades at a 33% premium over our quantitative fair value estimate of $53.72 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The company's valuation metrics decrease our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 16.3%, which ranks in the bottom 20% compared with global peers. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our view that shares are expensive.

The company's unfavorable dividend structure is an additional cause for concern. Dividends represent a stable form of future cash flows returned to shareholders, and low dividend payments can increase the perceived risk of a business. The firm's forward dividend yield of 0%, for example, lies in the bottom 30% compared with global peers. This could imply a planned dividend cut or relatively high share price, which further promotes our unfavorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

Economic moat

The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-11-20 20:02:24 · For reference only, not investment advice and not tailored to your situation.

BrightSpring Health Services discussion 0 comments

Add a comment